Fluvastatin reduces modification of low-density lipoprotein in hyperlipidemic rabbit loaded with oxidative stress (Q43880291)

27 November 2017

title

Fluvastatin reduces modification of low-density lipoprotein in hyperlipidemic rabbit loaded with oxidative stress (English)

1 reference

27 November 2017

1 reference

1 reference

Yu Yamaguchi

1

1 reference

27 November 2017

Sachiko Matsuno

2

1 reference

27 November 2017

Satomi Kagota

3

1 reference

27 November 2017

Jun Haginaka

4

1 reference

27 November 2017

Masaru Kunitomo

5

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 February 2002

1 reference

European Journal of Pharmacology

27 November 2017

published in

1 reference

27 November 2017

volume

436

1 reference

27 November 2017

issue

1-2

1 reference

27 November 2017

page(s)

97-105

1 reference

Macrophage foam cell formation during early atherogenesis is determined by the balance between pro-oxidants and anti-oxidants in arterial cells and blood lipoproteins

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901576-X

Influence of low HDL on progression of coronary artery disease and response to fluvastatin therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901576-X

Inhibitory effect of fluvastatin at doses insufficient to lower serum lipids on the catheter-induced thickening of intima in rabbit femoral artery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901576-X

Fluvastatin suppresses atherosclerotic progression, mediated through its inhibitory effect on endothelial dysfunction, lipid peroxidation, and macrophage deposition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901576-X

Direct vascular effects of HMG-CoA reductase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901576-X

On the role of vitamin C and other antioxidants in atherogenesis and vascular dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901576-X

Effect of vitamin E on atherogenesis in LDL receptor-deficient rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901576-X

The effect of vitamin E and vitamin C supplementation on LDL oxidizability and neutrophil respiratory burst in young smokers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901576-X

Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901576-X

Effects of fluvastatin on coronary atherosclerosis in patients with mild to moderate cholesterol elevations (Lipoprotein and Coronary Atherosclerosis Study [LCAS])

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901576-X

Reduced susceptibility of low density lipoprotein (LDL) to lipid peroxidation after fluvastatin therapy is associated with the hypocholesterolemic effect of the drug and its binding to the LDL

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901576-X

Cigarette smoke-modified low density lipoprotein impairs endothelium-dependent relaxation in isolated rabbit arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901576-X

Functional evidence for anti-oxidant action of fluvastatin on low-density lipoprotein using isolated macrophages and aorta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901576-X

A HMG-CoA reductase inhibitor improved regression of atherosclerosis in the rabbit aorta without affecting serum lipid levels: possible relevance of up-regulation of endothelial NO synthase mRNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901576-X

Effects of fluvastatin on leukocyte-endothelial cell adhesion in hypercholesterolemic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901576-X

Cholesterol metabolism in serum and aorta of inbred mice fed a high-cholesterol diet

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901576-X

The oxidative modification of low-density lipoproteins by macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901576-X

Effects of fluvastatin therapy on lipids, antioxidants, oxidation of low density lipoproteins and trace metals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901576-X

Inhibitory effects of fluvastatin, a new HMG-CoA reductase inhibitor, on the increase in vascular ACE activity in cholesterol-fed rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901576-X

Inhibitory effect of fluvastatin, an HMG-CoA reductase inhibitor, on the expression of adhesion molecules on human monocyte cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901576-X

Protective effect of fluvastatin, a new inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on MPP(+)-induced hydroxyl radical in the rat striatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901576-X

Fluvastatin, a new inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, resists hydroxyl radical generation in the rat myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901576-X

The effect of fluvastatin on cardiac events in patients with symptomatic coronary artery disease during one year of treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901576-X

Smoking influences the atherogenic potential of low-density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901576-X

A randomized placebo-controlled trial of fluvastatin for prevention of restenosis after successful coronary balloon angioplasty; final results of the fluvastatin angiographic restenosis (FLARE) trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901576-X

HMG CoA reductase inhibitors. In vivo effects on carotid intimal thickening in normocholesterolemic rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901576-X

Protective effect of fluvastatin sodium (XU-62-320), a 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor, on oxidative modification of human low-density lipoprotein in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901576-X

In vitro inhibitory effects of the optical isomers and metabolites of fluvastatin on copper ion-induced LDL oxidation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901576-X

Fluvastatin normalizes the decreased turnovers of glutathione and ascorbic acid in Watanabe heritable hyperlipidaemic rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901576-X

A simple fluorometric assay for lipoperoxide in blood plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901576-X

Evidence of modified lipoprotein in the plasma of Watanabe heritable hyperlipidemic rabbits by anion-exchange high-performance liquid chromatographic assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901576-X

Anion-exchange high-performance liquid chromatographic assay of plasma lipoproteins of rabbits, rats and mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901576-X

Peroxynitrite-generating species: good candidate oxidants in aqueous extracts of cigarette smoke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901576-X

Evidence of modified LDL in the plasma of hypercholesterolemic WHHL rabbits injected with aqueous extracts of cigarette smoke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901576-X

Oxidants in cigarette smoke extract modify low-density lipoprotein in the plasma and facilitate atherogenesis in the aorta of Watanabe heritable hyperlipidemic rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901576-X

Fluvastatin, an inhibitor of 3-hydroxy-3-methylglutaryl-CoA reductase, scavenges free radicals and inhibits lipid peroxidation in rat liver microsomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901576-X

Fluvastatin, an HMG-CoA reductase inhibitor, protects LDL from oxidative modification in hypercholesterolemic rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901576-X

Cholesteryl ester accumulation in macrophages incubated with low density lipoprotein pretreated with cigarette smoke extract

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901576-X

Decrease in reactive amino groups during oxidation or endothelial cell modification of LDL. Correlation with changes in receptor-mediated catabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901576-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-2999(01)01576-X

1 reference

27 November 2017

1 reference